Modulators of microglia activation and polarization in ischemic stroke (Review)
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
Ischemic stroke is one of the leading causes of mortality and disability worldwide. However, there is a current lack of effective therapies available. As the resident macrophages of the brain, microglia can monitor the microenvironment and initiate immune responses. In response to various brain injuries, such as ischemic stroke, microglia are activated and polarized into the proinflammatory M1 phenotype or the anti‑inflammatory M2 phenotype. The immunomodulatory molecules, such as cytokines and chemokines, generated by these microglia are closely associated with secondary brain damage or repair, respectively, following ischemic stroke. It has been shown that M1 microglia promote secondary brain damage, whilst M2 microglia facilitate recovery following stroke. In addition, autophagy is also reportedly involved in the pathology of ischemic stroke through regulating the activation and function of microglia. Therefore, this review aimed to provide a comprehensive overview of microglia activation, their functions and changes, and the modulators of these processes, including transcription factors, membrane receptors, ion channel proteins and genes, in ischemic stroke. The effects of autophagy on microglia polarization in ischemic stroke were also reviewed. Finally, future research areas of ischemic stroke and the implications of the current knowledge for the development of novel therapeutics for ischemic stroke were identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Zhang, Y., Xu, N., Ding, Y., Zhang, Y., Li, Q., Flores, J., Haghighiabyaneh, M., Doycheva, D., Tang, J., & Zhang, J. H. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.015 · Cited by 83
RetractedJi, J., Xiang, P., Li, T., Lan, L., Xu, X., Guo, L., Ji, H., Zhang, Y., & Li, Y. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00154 · Cited by 72
RetractedJauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 3,994
Johnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,264
Feigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L., & Parag, V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70025-0 · Cited by 2,855 · cited 1×
“…to 1 month) in both high-income and low-middle-income countries increased gradually from 2000 to 2008, from 13 to 23% and 13 to 19%, respectively (3,4). currently, intravenous thrombolysis and mechanical thrombectomy are the only effective means of treating ischemic stroke (5,6); however, these…”
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,075
Hu, X., Li, P., Guo, Y., Wang, H., Leak, R. K., Chen, S., Gao, Y., & Chen, J. (2012) · Stroke · doi:10.1161/strokeaha.112.659656 · Cited by 1,535
Chamorro, Á., Dirnagl, U., Urra, X., & Planas, A. M. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00114-9 · Cited by 1,198
Cited by
Microglia polarization from M1 to M2 in neurodegenerative diseases
Guo, S., Wang, H., & Yin, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.815347 · Cited by 920
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
“Significantly, the activation of PPAR-γ signaling by Interleukin-4 (IL-4) drives microglial polarization toward the M2 phenotype (Jiang et al., 2020).”
BackgroundLi, L., Jiang, W., Yu, B., Liang, H., Mao, S., Hu, X., Feng, Y., Xu, J., & Chu, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115653 · Cited by 278
Natural medicine in neuroprotection for ischemic stroke: Challenges and prospective
Tao, T., Liu, M., Chen, M., Luo, Y., Wang, C., Xu, T., Jiang, Y., Guo, Y., & Zhang, J. H. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107695 · Cited by 256
The Translational Potential of Microglia and Monocyte-Derived Macrophages in Ischemic Stroke
Wicks, E. E., Ran, K. R., Kim, J. E., Xu, R., Lee, R. P., & Jackson, C. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897022 · Cited by 92
Beccari, S., Sierra-Torre, V., Valero, J., Pereira-Iglesias, M., García-Zaballa, M., Soria, F. N., De Las Heras-Garcia, L., Carretero-Guillen, A., Capetillo-Zarate, E., Domercq, M., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2165313 · Cited by 89
“The field is still categorizing pro- or antiinflammatory microglia using outdated terms [72,73], such as M1 and M2 to define presumed beneficial or detrimental subtypes [3,70,71,74,75].”
MethodBarca, C., Foray, C., Hermann, S., Herrlinger, U., Remory, I., Laoui, D., Schäfers, M., Grauer, O. M., Zinnhardt, B., & Jacobs, A. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.787307 · Cited by 64
MiRNA: Involvement of the MAPK Pathway in Ischemic Stroke. A Promising Therapeutic Target
Gugliandolo, A., Silvestro, S., Sindona, C., Bramanti, P., & Mazzon, E. (2021) · Medicina · doi:10.3390/medicina57101053 · Cited by 49
Li, Y., Zhang, Y., Wang, Q., Wu, C., Du, G., & Yang, L. (2023) · Pharmaceuticals · doi:10.3390/ph16040621 · Cited by 24
“The microglia/macrophage M2-to-M1 shift during chronic inflammation after stroke expands neuronal damage and reduces neuronal self-restorative abilities [17].”
BackgroundInfluential
Metadata
- Authors
- Jiang, C., Wu, W., Deng, Y., & Ge, J.
- Venue
- Molecular Medicine Reports
- Publisher
- Spandidos Publications
- Published
- 2020-02-26
- Volume
- 21
- Issue
- 5
- Pages
- 2006-2018
- ISSN
- 1791-2997 (ISSN-L)
- 1791-3004
- OpenAlex
- W3008348330
- Cited by
- 309
- References
- 120
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.